IGXT:OTCPK (Canada) Also trade in: Canada Germany

Intelgenx Technologies Corp

$ 0.54 0.02 (3.28%)
Volume: 159,079 Avg Vol (1m): 286,580
Market Cap $: 50.67 Mil Enterprise Value $: 47.63 Mil
P/E (TTM): 0.00 P/B: 4.78
Earnings Power Value -0.9
Net Current Asset Value 0.03
Tangible Book 0.11
Projected FCF -0.52
Median P/S Value 0.32
Graham Number 0
Peter Lynch Value 0
DCF (FCF Based) 0
DCF (Earnings Based) 0
YTD (-%)

Financial Strength : 4/10

Current vs industry vs history
Cash-to-Debt 1.38
Equity-to-Asset 0.50
Debt-to-Equity 0.80
Debt-to-EBITDA -0.96
Piotroski F-Score 4
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0.03
DISTRESS
GREY
SAFE
Beneish M-Score -1.46
Not Manipulator
Manipulator
WACC vs ROIC %
ROIC -132.21%
WACC 16.05%

Profitability & Growth : 5/10

Current vs industry vs history
Operating Margin % -493.31
Net Margin % -554.17
ROE % -282.79
ROA % -75.13
ROC (Joel Greenblatt) % -143.03
3-Year Total Revenue Growth Rate -29.00

» IGXT's 30-Y Financials

Financials (Next Earnings Date: )

Guru Trades Click for details

» Details

Insider Trades

SEC Filings

Gurus Latest Trades with OTCPK:IGXT

» Interactive Chart

Peter Lynch Chart

Business Description

Industry Biotechnology » Biotechnology    NAICS : 325412    SIC : 2834
Compare XCNQ:BE NAS:NVUS XPAR:CEREN OTCPK:QBIO NAS:INNT ROCO:4195 OTCPK:DYAI OSTO:ENZY NAS:AQB AMEX:BPMX ASX:IMM TSX:BLU XCNQ:MMJ OSTO:IMMU XTER:MGN OTCPK:ARTH OTCPK:CRYO OSTO:ACTI NAS:CLSN NAS:CLBS
Traded in other countries IGX.Canada 0IL.Germany
Address 6420 Abrams, Ville Saint Laurent, QC, CAN, H4S 1Y2
Intelgenx Technologies Corp is an oral drug delivery company. The company is focused on the development and manufacturing of pharmaceutical oral films based on its proprietary VersaFilmTM technology platform. Intelegenx focuses on the development of novel oral immediate-release and controlled-release products for the pharmaceutical market. Intelegenx offers its partners a comprehensive portfolio of pharmaceutical services, including pharmaceutical R&D, clinical monitoring, regulatory support, tech transfer and manufacturing scale-up, and commercial manufacturing.

Ratios

Current vs industry vs history
PB Ratio 4.78
PS Ratio 22.49
EV-to-EBIT -5.29
EV-to-EBITDA -5.75
EV-to-Revenue 26.00
Current Ratio 4.80
Quick Ratio 4.66
Days Inventory 288.16
Days Sales Outstanding 163.09
Days Payable 7.00

Dividend & Buy Back

Current vs industry vs history
3-Year Share Buyback Rate -5.30

Valuation & Return

Current vs industry vs history
Price-to-Tangible-Book 4.91
Price-to-Median-PS-Value 1.69
Earnings Yield (Joel Greenblatt) % -18.93

More Statistics

Revenue (TTM) (Mil) $ 1.82
EPS (TTM) $ -0.14
Beta 2.41
Volatility % 102.11
52-Week Range $ 0.43 - 1.83
Shares Outstanding (Mil) 93.53

Analyst Estimate

Piotroski F-Score Details

Piotroski F-Score 4
Positive ROA N
Positive CFROA N
Higher ROA yoy N
CFROA > ROA Y
Lower Leverage yoy Y
Higher Current Ratio yoy Y
Less Shares Outstanding yoy N
Higher Gross Margin yoy Y
Higher Asset Turnover yoy N